Tumor Molecular Profiling in Early Phase Clinical Trials

Recruiting now

Conditions studied: Advanced Solid Tumor, Lymphoma

In brief

Prospective, single centre, non-interventional exploratory research project that will be conducted on biological material and health-related personal data collected.

Key facts

Study ID: NCT04510766
Run by: Oncology Institute of Southern Switzerland
People needed: 40
Starts: 2020-10-01
Expected to finish: 2026-12-31
Last updated by the study team: 2025-11-18

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

Male or female patients age at least 18 years.
Patients with histological diagnosis of advanced solid tumor or lymphoma who are potential candidates for early phase clinical trials.
Eastern Cooperative Oncology Group (ECOG) Performance Status 0 or 1
Live expectancy of at least 6 months.
Availability of FFPE archival tumor tissue from previous surgery or diagnostic biopsy adequate for molecular analysis.
Ability to understand the patient information and study consent. Signed and dated written informed consent must be available before performing any study-related procedure.
Willing and able to comply with study procedures

You may not qualify if…

Presence of any clinical (e.g. concomitant disease, clinically significant symptoms, or non-clinical (psychological or social) conditions that would not make the patient eligible for enrolment in an early phase clinical trial.
Any other active malignancy (other than the one for which the subject is being assessed for trial option) that is progressing or requiring active treatment with the exception of basal or squamous cell skin cancer, superficial bladder cancer, carcinoma in situ of any site.

Where it is running

Oncology Institute of Southern Switzerland — Bellinzona, Switzerland (enrolling)

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.